PL1909843T3 - Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji - Google Patents
Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacjiInfo
- Publication number
- PL1909843T3 PL1909843T3 PL06762981T PL06762981T PL1909843T3 PL 1909843 T3 PL1909843 T3 PL 1909843T3 PL 06762981 T PL06762981 T PL 06762981T PL 06762981 T PL06762981 T PL 06762981T PL 1909843 T3 PL1909843 T3 PL 1909843T3
- Authority
- PL
- Poland
- Prior art keywords
- bioconjugates
- anticancer
- hyaluronic acid
- pharmaceutical field
- chemical coupling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000242A ITPD20050242A1 (it) | 2005-08-03 | 2005-08-03 | Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1909843T3 true PL1909843T3 (pl) | 2017-03-31 |
Family
ID=37038336
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11159649T PL2540319T3 (pl) | 2005-08-03 | 2006-08-02 | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne |
| PL11159629T PL2537533T3 (pl) | 2005-08-03 | 2006-08-02 | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne |
| PL06762981T PL1909843T3 (pl) | 2005-08-03 | 2006-08-02 | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11159649T PL2540319T3 (pl) | 2005-08-03 | 2006-08-02 | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne |
| PL11159629T PL2537533T3 (pl) | 2005-08-03 | 2006-08-02 | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9687558B2 (pl) |
| EP (4) | EP2537533B1 (pl) |
| JP (2) | JP5457672B2 (pl) |
| KR (1) | KR101614157B1 (pl) |
| CN (2) | CN101267840B (pl) |
| AU (1) | AU2006274992B2 (pl) |
| BR (1) | BRPI0614536A2 (pl) |
| CA (1) | CA2616957C (pl) |
| DK (2) | DK2540319T3 (pl) |
| ES (4) | ES2596877T3 (pl) |
| IL (1) | IL189078A0 (pl) |
| IT (1) | ITPD20050242A1 (pl) |
| NO (1) | NO20080564L (pl) |
| NZ (1) | NZ565504A (pl) |
| PL (3) | PL2540319T3 (pl) |
| RU (1) | RU2411958C2 (pl) |
| SI (3) | SI2537533T1 (pl) |
| WO (1) | WO2007014784A2 (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007004675A1 (ja) * | 2005-07-06 | 2007-01-11 | Seikagaku Corporation | 薬剤導入光架橋ヒアルロン酸誘導体ゲル |
| ITMI20071267A1 (it) | 2007-06-22 | 2008-12-23 | Fidia Farmaceutici | Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative |
| IE20070900A1 (en) * | 2007-12-12 | 2009-06-24 | Eurand Pharmaceuticals Ltd | New anticancer conjugates |
| KR101224711B1 (ko) * | 2008-01-30 | 2013-01-21 | 유니버시티 오브 캔사스 | 림프관내 화학요법 약물 담체 |
| US20120100218A1 (en) * | 2008-01-30 | 2012-04-26 | Laird Forrest | Intralymphatic Chemotherapy Drug Carriers |
| IT1391006B1 (it) * | 2008-10-08 | 2011-10-27 | Fidia Farmaceutici | Uso terapeutico di nuove preparazioni farmaceutiche contenenti farmaci antitumorali legati all'acido ialuronico nel trattamento delle neoplasie |
| BRPI0910570A2 (pt) * | 2008-04-22 | 2015-09-22 | Fidia Farmaceutici | uso de bioconjugados, e, formulações farmacêuticas |
| KR20110032561A (ko) * | 2009-09-23 | 2011-03-30 | 포항공과대학교 산학협력단 | 약물 전달체의 표적 특이성 조절 방법, 표적 특이적 약물 전달체, 및 표적-비특이적 약효 장기 지속성 약물 전달체 |
| CN102399295B (zh) | 2010-09-09 | 2013-11-06 | 常州百瑞吉生物医药有限公司 | 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途 |
| CA2910325A1 (en) * | 2013-04-25 | 2014-10-30 | Aluron Biopharma Inc. | Crosslinked hyaluronic acid compositions |
| US20160158369A1 (en) * | 2013-07-10 | 2016-06-09 | Seikagaku Corporation | Pharmaceutical composition for respiratory administration |
| CZ305153B6 (cs) * | 2014-03-11 | 2015-05-20 | Contipro Biotech S.R.O. | Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití |
| CN104497167B (zh) * | 2014-11-24 | 2017-05-17 | 山东省药学科学院 | 透明质酸衍生物及其治疗药物 |
| CN105727305B (zh) * | 2016-02-24 | 2018-09-07 | 温州医科大学 | 一种Legumain响应释放阿霉素缓释纳米制剂及制备方法与作为制备载体药物的应用 |
| WO2019238954A1 (en) | 2018-06-15 | 2019-12-19 | Croma-Pharma Gmbh | Hydrogel composition comprising a crosslinked polymer |
| ES3061777T3 (en) | 2018-06-15 | 2026-04-07 | Croma Pharma Gmbh | Hydrogel composition comprising a crosslinked polymer |
| CN108912245B (zh) * | 2018-07-13 | 2020-04-28 | 吉林大学 | 一种具有靶向性和抗炎活性的氟化透明质酸衍生物及其制备方法和应用 |
| US20220040318A1 (en) * | 2018-09-28 | 2022-02-10 | Seikagaku Corporation | Primary amine compound or secondary amine compound-acidic polysaccharide conjugate and production method therefor |
| EP4077402B1 (en) | 2019-12-19 | 2024-05-01 | Croma-Pharma GmbH | Thiol-modified hyaluronan and hydrogel comprising the crosslinked hyaluronan |
| WO2021252513A1 (en) * | 2020-06-08 | 2021-12-16 | Aihol Corporation | Uses of hyaluronan conjugate |
| CN111892668B (zh) * | 2020-07-03 | 2022-07-12 | 广东工业大学 | 一种化合物及其制备方法、荧光探针和抗肿瘤药物 |
| CN112089690A (zh) * | 2020-08-31 | 2020-12-18 | 厦门大学 | 一种透明质酸化青蒿琥酯、其纳米胶束制剂及其制备方法和用途 |
| CN112608397B (zh) * | 2020-11-30 | 2021-12-28 | 西安交通大学 | 一种铂类抗肿瘤药物-多糖聚合物纳米前药及制备方法和应用 |
| AU2022291922B2 (en) * | 2021-06-18 | 2024-07-25 | Aihol Corporation | Uses of hyaluronan conjugate |
| WO2025174913A1 (en) * | 2024-02-12 | 2025-08-21 | Prolynx Llc | Locoregional therapies using slow-release conjugates |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2553099B1 (fr) | 1983-10-11 | 1989-09-08 | Fidia Spa | Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| WO1992006714A1 (fr) * | 1990-10-18 | 1992-04-30 | Shiseido Co., Ltd. | Combinaison d'acide hyaluronique avec un ingredient medicinal et sa production |
| IT1247175B (it) | 1991-04-19 | 1994-12-12 | Fidia Spa | Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico. |
| AU4406793A (en) * | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
| ES2149867T3 (es) | 1993-02-26 | 2000-11-16 | Drug Delivery System Inst Ltd | Derivados de polisacaridos y soportes para farmacos. |
| GB9320781D0 (en) * | 1993-10-08 | 1993-12-01 | Erba Carlo Spa | Polymer-bound camptothecin derivatives |
| US5616568A (en) * | 1993-11-30 | 1997-04-01 | The Research Foundation Of State University Of New York | Functionalized derivatives of hyaluronic acid |
| ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| CA2192725C (en) | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Camptothecin derivatives |
| CN1304058C (zh) | 1996-03-12 | 2007-03-14 | Pg－Txl有限公司 | 水溶性紫杉醇产品 |
| TW409058B (en) | 1996-06-06 | 2000-10-21 | Daiichi Seiyaku Co | Method for preparation of a drug complex |
| ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| HUP0204562A2 (hu) * | 2000-03-17 | 2003-04-28 | Cell Therapeutics, Inc. | Poliglutaminsav-kamptotecin konjugátumok, eljárás előállításukra és ilyen konjugátumokat tartalmazó gyógyászati készítmények |
| GB0012718D0 (en) * | 2000-05-24 | 2000-07-19 | Angeletti P Ist Richerche Bio | Conjugates of aminodrugs |
| IT1317359B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
| IT1317358B1 (it) | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Derivati cross-linkati dell'acido ialuronico. |
| EP1610751A4 (en) * | 2001-04-26 | 2006-05-24 | Univ Texas | THERAPEUTIC AGENT / LIGAND CONJUGATE COMPOSITIONS, ITS SYNTHESIS PROCESSES AND ITS APPLICATION |
| EP1401875A4 (en) | 2001-05-04 | 2005-01-26 | Univ Utah Res Found | HYALURONIC ACID-CONTAINING BIOKON JUGATES: TARGETED DELIVERY OF ANTIBODIES TO CANCER CELLS |
| US7034127B2 (en) * | 2002-07-02 | 2006-04-25 | Genzyme Corporation | Hydrophilic biopolymer-drug conjugates, their preparation and use |
| ITPD20020271A1 (it) * | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
-
2005
- 2005-08-03 IT IT000242A patent/ITPD20050242A1/it unknown
-
2006
- 2006-08-02 ES ES06762981.6T patent/ES2596877T3/es active Active
- 2006-08-02 ES ES11159629.2T patent/ES2633290T3/es active Active
- 2006-08-02 JP JP2008524445A patent/JP5457672B2/ja active Active
- 2006-08-02 WO PCT/EP2006/007717 patent/WO2007014784A2/en not_active Ceased
- 2006-08-02 SI SI200632189T patent/SI2537533T1/sl unknown
- 2006-08-02 DK DK11159649.0T patent/DK2540319T3/en active
- 2006-08-02 NZ NZ565504A patent/NZ565504A/en unknown
- 2006-08-02 CN CN200680034187.0A patent/CN101267840B/zh active Active
- 2006-08-02 AU AU2006274992A patent/AU2006274992B2/en active Active
- 2006-08-02 BR BRPI0614536-1A patent/BRPI0614536A2/pt not_active IP Right Cessation
- 2006-08-02 EP EP11159629.2A patent/EP2537533B1/en active Active
- 2006-08-02 SI SI200632120A patent/SI1909843T1/sl unknown
- 2006-08-02 ES ES11159649.0T patent/ES2633291T3/es active Active
- 2006-08-02 CA CA2616957A patent/CA2616957C/en active Active
- 2006-08-02 US US11/989,716 patent/US9687558B2/en active Active
- 2006-08-02 KR KR1020087004522A patent/KR101614157B1/ko active Active
- 2006-08-02 PL PL11159649T patent/PL2540319T3/pl unknown
- 2006-08-02 EP EP06762981.6A patent/EP1909843B1/en active Active
- 2006-08-02 PL PL11159629T patent/PL2537533T3/pl unknown
- 2006-08-02 EP EP11159664.9A patent/EP2548582B1/en active Active
- 2006-08-02 ES ES11159664.9T patent/ES2692619T3/es active Active
- 2006-08-02 CN CN201210568694XA patent/CN103041402A/zh active Pending
- 2006-08-02 SI SI200632187T patent/SI2540319T1/sl unknown
- 2006-08-02 DK DK11159629.2T patent/DK2537533T3/da active
- 2006-08-02 PL PL06762981T patent/PL1909843T3/pl unknown
- 2006-08-02 RU RU2008102878/05A patent/RU2411958C2/ru active
- 2006-08-02 EP EP11159649.0A patent/EP2540319B1/en active Active
-
2008
- 2008-01-28 IL IL189078A patent/IL189078A0/en active IP Right Grant
- 2008-01-30 NO NO20080564A patent/NO20080564L/no not_active Application Discontinuation
-
2013
- 2013-10-10 JP JP2013212756A patent/JP2014001249A/ja not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1909843T3 (pl) | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji | |
| NO20200320A1 (no) | Sammensetninger og fremgangsmåter for fremstilling av lite vannoppløselige medikamenter med økt stabilitet | |
| IL199151A (en) | Pyrimidine derivatives, their pharmaceutical preparations, their use in cancer treatment and their kits | |
| GB2431876B (en) | Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions | |
| PL1861387T3 (pl) | Pochodne benzoimidazolu i ich kompozycje farmaceutyczne | |
| IL197451A (en) | History of Phenylamino and 4-Phenylalkylamino Quinazoline and Pharmaceuticals Containing It | |
| IL193467A0 (en) | Substituted indazole derivatives, their manufacture and use as pharmaceutical agents | |
| BRPI0813105A2 (pt) | Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo | |
| BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
| BRPI0811871A2 (pt) | Composições agroquímicas ácidas bioativas e uso das mesmas | |
| IL190292A (en) | History of pyridopyrimidinone and their pharmaceutical preparations | |
| IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
| ATE544759T1 (de) | 5-pyridinon-substituierte indazole und pharmazeutische zusammensetzungen davon | |
| DK1922309T3 (da) | N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf | |
| PT1861387E (pt) | Derivados de benzimidazol e composições farmacêuticas dos mesmos | |
| IL194880A (en) | Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them | |
| BRPI0910570A2 (pt) | uso de bioconjugados, e, formulações farmacêuticas | |
| BRPI0821455A2 (pt) | Composições farmacêuticas de amlopidina e valsartan | |
| ITPD20050168A1 (it) | Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico | |
| ITPD20050056A1 (it) | Derivati ammidici del'acido ialuronico in osteoartrosi | |
| PT1858481T (pt) | Composições oftalmológicas e sua utilização | |
| PL377180A1 (pl) | Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz | |
| DK2222275T3 (da) | Farmaceutiske sammensætninger indeholdende bradykininantagonister og hyaluronsyre og anvendelser deraf | |
| IL185096A0 (en) | Polymer compositions and their use in the production of active or effective ingredient compositions | |
| BRPI0719997A2 (pt) | Uso de epotilonas no tratamento de osteoporose e doenças relacionadas |